D0242 Microarray analysis reveals adaptive strategies of Tribolium castaneum larvae to compensate for cysteine and serine protease inhibitors

Tuesday, December 14, 2010
Grand Exhibit Hall (Town and Country Hotel and Convention Center)
Brenda Oppert , USDA ARS CGAHR, Manhattan, KS
Michelle J Toutges , USDA ARS CGAHR, Manhattan, KS
Elena N Elpidina , Moscow State University, Moscow, Russia
Sudeshna Mazumdar-Leighton , Insect-Plant Interactions group, Delhi University, New Delhi, Delhi, India
The transcriptome response of Tribolium castaneum larvae to dietary protease inhibitors was evaluated by whole-genome microarray analysis. RNA was isolated from guts of larvae fed control diet (no inhibitor), or diets containing 0.1% E-64 (cysteine protease inhibitor), 5.0% soybean trypsin inhibitor (STI, serine protease inhibitor), or a combination of 0.1% E-64 and 5.0% STI. Data were analyzed by pairwise analysis, in which each inhibitor treatment was compared to control, or ANOVA of control and all treatment groups. In pairwise analysis, the expression of only 253 genes was significantly altered (p<0.05) in response to STI treatment, whereas E-64 and combination treatments resulted in 1,574 and 1,584 differentially regulated genes. The data indicate that treatments containing E-64, whether alone or in combination, significantly impact gene expression in T. castaneum larvae. ANOVA analysis revealed 2,175 genes differentially expressed in inhibitor-treated larvae compared to control (p<0.05), including genes related to proteases that were mostly up-regulated, namely cathepsins B and L, chymotrypsins, and nonproteolytic cysteine cathepsin or serine protease homologs. Inhibitor treatments induced the differential expression of other gut-related genes, as well as genes encoding proteins of unknown function. These data suggest that T. castaneum larvae compensate for dietary cysteine protease inhibitors by altering large-scale gene expression patterns.

doi: 10.1603/ICE.2016.50511